Studie

A randomized multi-center treatment study (COALL 08-09) to improve the survival of children with acute lymphoblastic leukemia on behalf of the German Society of Pediatric Hematology and Oncology

Erkrankungsgruppe:

Leukämien und MDS

Organsystem:

Blut

Stadium:

Ersterkrankung

Standort:

Bonn

EudraCT:

2009-012758-18

Prüfplan-Code:

COALL09-05-04

Phase:

II/III

Prüfsubstanz:

Adriamycin, Clofarabin, Cytarabin, Daunorubicin, Dexamethason, Cyclophosphamid, Etoposid, Methotrexat, Methylprednisolon, 6-Mercaptopurin, 6-Thioguanin, Vincristin, PEG-Asparaginase, Amsacrin, Leukovorin, Nelarabin

Sponsor:

Universitätsklinikum Hamburg-Eppendorf